Federal contract award
75F40122C00202
PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.2M |
| Current contract value | $1.2M |
| Potential contract value / ceiling | $1.2M |
| Start date | Sep 27, 2022 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 29, 2026 |
| Latest award activity | Jul 31, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 31, 2025 | P00003 | $0 | PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS. |
| Aug 17, 2024 | P00002 | $245.1K | PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS. |
| Aug 21, 2023 | P00001 | $225.1K | PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS. |
| Sep 27, 2022 | 0 | $764.3K | PMQWP 345/CDER-2022-113555 - IMPROVE SCIENTIFIC APPROACHES TO EVALUATE GENERIC DRUGS. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.